Skip to main content

Advertisement

SpringerLink
Log in

Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

To investigate the possible association between systemic vasculitis and risk of venous thromboembolism (VTE), two investigators independently searched published studies indexed in MEDLINE, EMBASE, and the Cochrane database from inception to April 2016 using the terms for each type of vasculitis in conjunction with the terms for venous thromboembolism. The inclusion criteria were as follows: (1) observational studies published as original studies to evaluate the association between vasculitis and VTE, (2) odds ratios, relative risk or hazard ratio or standardized incidence ratio with 95 % confidence intervals (CI) were provided, and (3) participants without vasculitis were used as comparators for cohort studies and cross-sectional studies while participants without VTE were used as comparators for case-control studies. RevMan 5.3 software was used for the data analysis. Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird. Seven studies investigating the risk of VTE among patients with systemic vasculitis were identified. At least one study was available for three specific forms of vasculitis (polyarteritis nodosa [PAN], granulomatosis with polyangiitis [GPA], and giant cell arteritis [GCA]). An increased risk of VTE was seen in all three vasculitides (GPA, pooled RR 3.94, 95 % CI 1.11–14.01; PAN, pooled RR 3.00, 95 % CI 2.20–4.09; GCA, pooled RR 2.26, 95 % CI 1.38–3.71). This meta-analysis demonstrates that patients with systemic vasculitis may have a significantly increased risk of VTE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5(4):692–699. doi:10.1111/j.1538-7836.2007.02450

    Article  CAS  PubMed  Google Scholar 

  2. Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT (2007) Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 82(9):777–782. doi:10.1002/ajh.20983

    Article  PubMed  Google Scholar 

  3. Liao S, Woulfe T, Hyder S, Merriman E, Simpson D, Chunilal S (2014) Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study. J Thromb Haemost 12(2):214–219. doi:10.1111/jth.12464

    Article  CAS  PubMed  Google Scholar 

  4. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, et al. (1992) The clinical course of pulmonary embolism. N Engl J Med 326(19):1240–1245. doi:10.1056/NEJM199205073261902

    Article  CAS  PubMed  Google Scholar 

  5. Hawbaker S (2012) Venous thromboembolism in the cancer population: pathology, risk, and prevention. J Adv Pract Oncol 3(1):23–33

    PubMed  PubMed Central  Google Scholar 

  6. Ungprasert P, Srivali N, Wijarnpreecha K, Charoenpong P, Knight EL (2015) Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis. Rheumatology (Oxford) 54(4):736–742. doi:10.1093/rheumatology/keu408

    Article  Google Scholar 

  7. Yusuf HR, Hooper WC, Grosse SD, Parker CS, Boulet SL, Ortel TL (2015) Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. Thromb Res 135(1):50–57. doi:10.1016/j.thromres.2014.10.012

    Article  CAS  PubMed  Google Scholar 

  8. Ungprasert P, Sanguankeo A (2014) Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis. Rheumatol Int 34(10):1455–1458. doi:10.1007/s00296-014-3023-1

    Article  PubMed  Google Scholar 

  9. Ungprasert P, Sanguankeo A, Upala S, Suksaranjit P (2014) Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis. QJM 107(10):793–797. doi:10.1093/qjmed/hcu073

    Article  PubMed  Google Scholar 

  10. Ungprasert P, Srivali N, Spanuchart I, Thongprayoon C, Knight EL (2014) Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 33(3):297–304. doi:10.1007/s10067-014-2492-7

    Article  PubMed  Google Scholar 

  11. Koutroumpakis EI, Tsiolakidou G, Koutroubakis IE (2013) Risk of venous thromboembolism in patients with inflammatory bowel disease. Semin Thromb Hemost 39(5):461–468. doi:10.1055/s-0033-1343886

    Article  CAS  PubMed  Google Scholar 

  12. Nagareddy P, Smyth SS (2013) Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol 20(5):457–463. doi:10.1097/MOH.0b013e328364219d

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Mahr A, de Menthon M (2015) Classification and classification criteria for vasculitis: achievements, limitations and prospects. Curr Opin Rheumatol 27(1):1–9. doi:10.1097/BOR.0000000000000134

    Article  PubMed  Google Scholar 

  14. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd-Chiari syndrome: a common complication of Behcet's disease. Am J Gastroenterol 92(5):858–862

    CAS  PubMed  Google Scholar 

  15. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. doi:10.1007/s10654-010-9491-z

    Article  PubMed  Google Scholar 

  16. Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A (2013) Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 13:154. doi:10.1186/1471-2458-13-154

    Article  PubMed  PubMed Central  Google Scholar 

  17. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  CAS  PubMed  Google Scholar 

  18. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. doi:10.1136/bmj.327.7414.557

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 9:1. doi: 10.1186/1741-7015-9-1.

  20. Zoller B, Li X, Sundquist J, Sundquist K (2012) Risk of venous thromboembolism in first- and second-generation immigrants in Sweden. Eur J Intern Med 23(1):40–47. doi:10.1016/j.ejim.2011.07.015

    Article  PubMed  Google Scholar 

  21. Deghan N AN, Shojania K, Sayre E, Avina-Zubieta A (2014). Venous thromboembolic events in patients with granulomatosis with polyangiitis: a population-based study presented at the Canadian Rheumatology Association-Arthritis Health Professionals Association Annual Scientific Meeting (Whistler, British Columbia, Canada)

  22. Faurschou M, Obel N, Baslund B (2014) High risk of pulmonary embolism and deep venous thrombosis but not of stroke in granulomatosis with polyangiitis (Wegener's. Arthritis Care Res (Hoboken) 66(12):1910–1914. doi:10.1002/acr.22423

    Article  Google Scholar 

  23. Avina-Zubieta JA, Bhole VM, Amiri N, Sayre EC, Choi HK (2016) The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study. Ann Rheum Dis 75(1):148–154. doi:10.1136/annrheumdis-2014-205665

    Article  PubMed  Google Scholar 

  24. Unizony S, Menendez ME, Rastalsky N, Stone JH (2015) Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency. Rheumatology (Oxford) 54(8):1360–1368. doi:10.1093/rheumatology/keu483

    Article  Google Scholar 

  25. Lo Gullo A, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Saitta A, et al. (2016) Venous thromboembolism and cerebrovascular events in patients with giant cell arteritis: a population-based retrospective cohort study. PLoS One 11(2):e0149579. doi:10.1371/journal.pone.0149579

    Article  PubMed  PubMed Central  Google Scholar 

  26. Balta S, Balta I, Ozturk C, Celik T, Iyisoy A (2016) Behcet's disease and risk of vascular events. Curr Opin Cardiol 31(4):451–457. doi:10.1097/HCO.0000000000000281

    Article  PubMed  Google Scholar 

  27. Sebastian JK, Voetsch B, Stone JH, Romay-Penabad Z, Lo GH, Allen NB, et al. (2007) The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. J Rheumatol 34(12):2446–2450

    PubMed  Google Scholar 

  28. Espinosa G, Tassies D, Font J, Munoz-Rodriguez FJ, Cervera R, Ordinas A, et al. (2001) Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis. Semin Arthritis Rheum 31(1):12–20

    Article  CAS  PubMed  Google Scholar 

  29. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y (2007) High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa. Arthritis Rheum 57(8):1507–1513. doi:10.1002/art.23081

    Article  CAS  PubMed  Google Scholar 

  30. Somers E, Magder LS, Petri M (2002) Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 29(12):2531–2536

    CAS  PubMed  Google Scholar 

  31. Manna R, Latteri M, Cristiano G, Todaro L, Scuderi F, Gasbarrini G (1998) Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol 37(2):208–210

    Article  CAS  PubMed  Google Scholar 

  32. Hulin C, Hachulla E, Michon-Pasturel U, Hatron PY, Masy E, Gillot JM, et al. (1999) Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica. Rev Med Interne 20(8):659–663

    Article  CAS  PubMed  Google Scholar 

  33. Meyer O, Nicaise P, Moreau S, de Bandt M, Palazzo E, Hayem G, et al. (1996) Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis. Rev Rhum Engl Ed 63(4):241–247

    CAS  PubMed  Google Scholar 

  34. Xu J, Lupu F, Esmon CT (2010) Inflammation, innate immunity and blood coagulation. Hamostaseologie 30(1):5–6 8-9

    CAS  PubMed  Google Scholar 

  35. Weidner S, Hafezi-Rachti S, Rupprecht HD (2006) Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 55(1):146–149. doi:10.1002/art.21704

    Article  PubMed  Google Scholar 

  36. Stassen PM, Derks RP, Kallenberg CG, Stegeman CA (2008) Venous thromboembolism in ANCA-associated vasculitis—incidence and risk factors. Rheumatology (Oxford) 47(4):530–534. doi:10.1093/rheumatology/ken035

    Article  CAS  Google Scholar 

  37. Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC Jr, et al. (2005) Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's clinical occurrence of thrombosis (WeCLOT) study. Ann Intern Med 142(8):620–626

    Article  PubMed  Google Scholar 

  38. Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L, et al. (2009) High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis 68(4):564–567. doi:10.1136/ard.2008.099051

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, 200 First street SW, Rochester, MN, 55905, USA

    Patompong Ungprasert, Matthew J. Koster & Kenneth J. Warrington

  2. Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA

    Charat Thongprayoon

Authors
  1. Patompong Ungprasert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew J. Koster
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charat Thongprayoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenneth J. Warrington
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patompong Ungprasert.

Ethics declarations

Disclosures

ᅟ

None.

ᅟ

Funding

None.

Electronic supplementary material

ESM 1

(DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ungprasert, P., Koster, M.J., Thongprayoon, C. et al. Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis. Clin Rheumatol 35, 2741–2747 (2016). https://doi.org/10.1007/s10067-016-3394-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3394-7

Keywords

Search

Navigation